Brain abscess: Difference between revisions
From IDWiki
No edit summary |
(→) |
||
Line 3: | Line 3: | ||
===Microbiology=== |
===Microbiology=== |
||
*Direct spread |
*Direct spread (50%) |
||
**'''Nose/sinuses:''' [[Streptococcus species]] (especially |
**'''Nose/sinuses:''' [[Streptococcus species]] (especially [[Streptococcus anginosus group]]), [[Haemophilus species]], [[Bacteroides species]], [[Fusobacterium species]] |
||
**'''Teeth:''' [[Streptococcus species]], [[Bacteroides species]], [[Prevotella species]], [[Fusobacterium species]], [[Haemophilus species]] |
**'''Teeth:''' [[Streptococcus species]], [[Bacteroides species]], [[Prevotella species]], [[Fusobacterium species]], [[Haemophilus species]] |
||
**'''Ears:''' [[Enterobacteriaceae]], [[Streptococcus species]], [[Pseudomonas aeruginosa]], [[Bacteroides species]] |
**'''Ears:''' [[Enterobacteriaceae]], [[Streptococcus species]], [[Pseudomonas aeruginosa]], [[Bacteroides species]] |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
**'''Lungs:''' [[Streptococcus species]], [[Fusobacterium species]], [[Actinomyces species]] |
**'''Lungs:''' [[Streptococcus species]], [[Fusobacterium species]], [[Actinomyces species]] |
||
**'''Urinary tract:''' [[Pseudomonas aeruginosa]], [[Enterobacter species]] |
**'''Urinary tract:''' [[Pseudomonas aeruginosa]], [[Enterobacter species]] |
||
**'''Endocarditis:''' [[Viridans group streptococci]], [[Staphylococcus aureus]] |
**'''Endocarditis:''' [[Viridans group streptococci]], [[Staphylococcus aureus]] |
||
**'''Congenital cardiac malformations''' (especially right-to-left shunts): [[Streptococcus species]] |
**'''Congenital cardiac malformations''' (especially right-to-left shunts): [[Streptococcus species]] |
||
*Direct inoculation (10%) |
|||
⚫ | |||
⚫ | |||
*Cryptogenic (15%) |
|||
*Immunocompromised patient |
*Immunocompromised patient |
||
**'''HIV:''' [[Toxoplasma gondii]], [[Nocardia species]], [[non-tuberculous mycobacteria]], [[Listeria monocytogenes]], [[Cryptococcus neoformans]] |
**'''HIV:''' [[Toxoplasma gondii]], [[Nocardia species]], [[non-tuberculous mycobacteria]], [[Listeria monocytogenes]], [[Cryptococcus neoformans]] |
||
Line 19: | Line 21: | ||
**'''Transplantation:''' [[Aspergillus species]], [[Candida species]], [[mucormycosis]], [[Scedosporium species]], [[Enterobacteriaceae]], [[Nocardia species]], [[Toxoplasma gondii]], and [[Mycobacterium tuberculosis]] |
**'''Transplantation:''' [[Aspergillus species]], [[Candida species]], [[mucormycosis]], [[Scedosporium species]], [[Enterobacteriaceae]], [[Nocardia species]], [[Toxoplasma gondii]], and [[Mycobacterium tuberculosis]] |
||
*Plus '''[[anaerobes]]''', which are common |
*Plus '''[[anaerobes]]''', which are common |
||
*Other organisms: [[Nocardia species]], [[Klebsiella pneumoniae]] (especially southeast Asia), [[Aspergillus]], [[Taenia solium]], and [[Toxoplasma gondii]] |
|||
===Pathophysiology=== |
|||
⚫ | |||
*Typically starts as a small focus of infection in the brain parenchyma, followed by cerebritis and eventual capsule formation to give an abscess |
|||
⚫ | |||
== Clinical Manifestations == |
|||
* Often non-specific |
|||
* Headache is most common, then fever and focal neurological deficits |
|||
* May have seizures |
|||
* May have symptoms of increase ICP, such as comiting, blurry vision, drowiness, and confusion |
|||
=== |
=== Prognosis and Complications === |
||
* 10% mortality |
|||
⚫ | |||
* 50% seizures |
|||
⚫ | |||
* 20% significant cognitive impairment |
|||
==Investigations== |
==Investigations== |
||
*MRI with gadolinium |
|||
*MRI |
|||
**Typically demonstrates a ring-enhancing lesion with thin rim |
|||
**Temporal lobe or cerebellum suggests contiguous spread from chronic otitis or mastoiditis |
**Temporal lobe or cerebellum suggests contiguous spread from chronic otitis or mastoiditis |
||
**Frontal lobe suggests contiguous spread from frontal or ethmoid sinusitis |
**Frontal lobe suggests contiguous spread from frontal or ethmoid sinusitis |
||
**Multiple abscesses in a middle cerebral artery distribution suggests bacteremia |
**Multiple abscesses in a middle cerebral artery distribution suggests bacteremia |
||
*Blood cultures positive in 15% |
|||
*Lumbar puncture usually contraindicated due to mass effect and risk of herniation |
|||
*Most important is aspiration of abscess for stain and culture, which is positive in 2/3 of cases |
|||
**Can do bacterial or fungal ribosomal PCR if cultures negative |
|||
==Management== |
==Management== |
||
*Empiric therapy is directed at the likely organisms based on etiology (direct vs. hematogenous spread) |
*Empiric therapy is directed at the likely organisms based on etiology (direct vs. hematogenous spread) |
||
*For likely oral, ear, or sinus source, treated with [[Is treated by::ceftriaxone]] and [[Is treated by::metronidazole]] at CNS doses |
**For likely oral, ear, or sinus source, treated with [[Is treated by::ceftriaxone]] and [[Is treated by::metronidazole]] at CNS doses |
||
*For likely hematogenous spread, treated with [[Is treated by::vancomycin]] |
**For likely hematogenous spread, treated with [[Is treated by::vancomycin]] |
||
*For uncertain etiology, combination of [[ceftriaxone]], [[metronidazole]], and [[vancomycin]] |
**For uncertain etiology, combination of [[ceftriaxone]], [[metronidazole]], and [[vancomycin]] |
||
*For neurosurgical patients, [[Is treated by::vancomycin]] plus a broad-spectrum [[Antipseudomonal antibiotics|antipseudomonal antibiotic]] such as [[Is treated by::ceftazidime]], [[Is treated by::cefepime]], or [[Is treated by::meropenem]] |
**For neurosurgical patients, [[Is treated by::vancomycin]] plus a broad-spectrum [[Antipseudomonal antibiotics|antipseudomonal antibiotic]] such as [[Is treated by::ceftazidime]], [[Is treated by::cefepime]], or [[Is treated by::meropenem]] |
||
*Source control with neurosurgical aspiration |
|||
*Duration is typically 6 to 8 weeks of intravenous antibiotics following source control |
|||
**Monitor with serial MRI, though abnormalities may persist after successful treatment |
|||
*No role for routine use of steroids |
|||
==Further Reading== |
==Further Reading== |
Revision as of 11:53, 18 August 2020
Background
Microbiology
- Direct spread (50%)
- Nose/sinuses: Streptococcus species (especially Streptococcus anginosus group), Haemophilus species, Bacteroides species, Fusobacterium species
- Teeth: Streptococcus species, Bacteroides species, Prevotella species, Fusobacterium species, Haemophilus species
- Ears: Enterobacteriaceae, Streptococcus species, Pseudomonas aeruginosa, Bacteroides species
- Hematogenous spread (25%)
- Lungs: Streptococcus species, Fusobacterium species, Actinomyces species
- Urinary tract: Pseudomonas aeruginosa, Enterobacter species
- Endocarditis: Viridans group streptococci, Staphylococcus aureus
- Congenital cardiac malformations (especially right-to-left shunts): Streptococcus species
- Direct inoculation (10%)
- Penetrating head trauma: Staphylococcus aureus, Enterobacter species, Clostridium species
- Neurosurgery: Staphylococcus species, Streptococcus species, Pseudomonas aeruginosa, Enterobacter species
- Cryptogenic (15%)
- Immunocompromised patient
- HIV: Toxoplasma gondii, Nocardia species, non-tuberculous mycobacteria, Listeria monocytogenes, Cryptococcus neoformans
- Neutropenia: Gram-negative bacilli, Aspergillus species, mucormycosis, Candida species, Scedosporium species
- Transplantation: Aspergillus species, Candida species, mucormycosis, Scedosporium species, Enterobacteriaceae, Nocardia species, Toxoplasma gondii, and Mycobacterium tuberculosis
- Plus anaerobes, which are common
- Other organisms: Nocardia species, Klebsiella pneumoniae (especially southeast Asia), Aspergillus, Taenia solium, and Toxoplasma gondii
Pathophysiology
- Either from contiguous spread from a head and neck infection, hematogenous spread from bacteremia or endocarditis, traumatic inoculation, or post-neurosurgery
- Typically starts as a small focus of infection in the brain parenchyma, followed by cerebritis and eventual capsule formation to give an abscess
- Microbiology (above) depends on mechanism of infection
Clinical Manifestations
- Often non-specific
- Headache is most common, then fever and focal neurological deficits
- May have seizures
- May have symptoms of increase ICP, such as comiting, blurry vision, drowiness, and confusion
Prognosis and Complications
- 10% mortality
- 50% seizures
- 20% significant cognitive impairment
Investigations
- MRI with gadolinium
- Typically demonstrates a ring-enhancing lesion with thin rim
- Temporal lobe or cerebellum suggests contiguous spread from chronic otitis or mastoiditis
- Frontal lobe suggests contiguous spread from frontal or ethmoid sinusitis
- Multiple abscesses in a middle cerebral artery distribution suggests bacteremia
- Blood cultures positive in 15%
- Lumbar puncture usually contraindicated due to mass effect and risk of herniation
- Most important is aspiration of abscess for stain and culture, which is positive in 2/3 of cases
- Can do bacterial or fungal ribosomal PCR if cultures negative
Management
- Empiric therapy is directed at the likely organisms based on etiology (direct vs. hematogenous spread)
- For likely oral, ear, or sinus source, treated with ceftriaxone and metronidazole at CNS doses
- For likely hematogenous spread, treated with vancomycin
- For uncertain etiology, combination of ceftriaxone, metronidazole, and vancomycin
- For neurosurgical patients, vancomycin plus a broad-spectrum antipseudomonal antibiotic such as ceftazidime, cefepime, or meropenem
- Source control with neurosurgical aspiration
- Duration is typically 6 to 8 weeks of intravenous antibiotics following source control
- Monitor with serial MRI, though abnormalities may persist after successful treatment
- No role for routine use of steroids
Further Reading
- Brain Abscesses. NEJM. 2015;371:447-456. doi: 10.1056/NEJMra1301635